Circulating tumor cells (CTCs) pose continuous and persistent threats to create new metastases albeit at an unknown, extremely low efficiency. Compared to single CTCs, clusters of multicellular CTCs possess 20-100 times higher metastatic capacity, create more polyclonal metastasis, and correlate with worse prognosis. Our previous studies identified that in addition to collective migration and cohesive shedding, tumor cell aggregation is a new mechanism for CTC cluster formation, enhancing cancer stemness and polyclonal metastasis. The objectives of this proposal are to elucidate the molecular mechanisms underlying CD44 and PAK2-promoted CTC aggregation, identify the drivers of CTC cluster-mediated polyclonal metastasis, and therefore develop proof-of-principle targeting strategies to block lung metastasis of triple negative breast cancer, using multiple human PDXs and CTC lines as well as mouse tumor models. The collaborative team includes Dr. Huiping Liu (Northwestern University) with expertise in CTC and cancer stemness, breast oncologist Dr. Massimo Cristofanilli (Northwestern University), imaging expert Dr. Constadina Arvanitis (Northwestern University), and bioinformaticist and structural biologist Dr. Yang Shen (Texas A & M).

Public Health Relevance

(Relevance to Public Health) Breast cancer is the leading cancer in women and claims about 40,000 lives in the United States every year. Metastasis account for 90% of breast cancer deaths. In order to develop effective treatments against cancer, we need to better understand the cellular and molecular mechanism underlying metastasis. Using clinical specimens, patient-derived xenograft models, and other cell line and models along with cutting-edge technology, this project aims to identify a novel mechanism critical for circulating tumor cell cluster formation and targeting strategies to block metastasis, thereby eventually contributing to a reduced mortality rate of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA245699-01A1S1
Application #
10145277
Study Section
Program Officer
Ault, Grace S
Project Start
2020-04-16
Project End
2022-03-31
Budget Start
2020-09-01
Budget End
2021-03-31
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611